BRIDGEBIO
Live / Registered — Registered (as of 06 Jul 2021)
What this means for you
Registered since 06 Jul 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90256769
- Registration number
- 6413178
- Mark type
- Stylized text
- Filed
- 15 Oct 2020
- Published for opposition
- 16 Feb 2021
- Registered
- 06 Jul 2021
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for use in the treatment of oncological, cardiological, dermatological, neurological, genetic, orthopedic and metabolic diseases and disorders
Owner
- Bridgebio Pharma, Inc., Palo Alto, CA, US
- Bridgebio Pharma, Inc., Palo Alto, CA, US
- Bridgebio Pharma, Inc., Palo Alto, CA, US
Prosecution history
- 06 Jul 2026 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 05 Mar 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 07 Dec 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 07 Dec 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 07 Dec 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 07 Dec 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 07 Dec 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 06 Jul 2021 — REGISTERED-PRINCIPAL REGISTER
- 29 May 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 28 May 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 22 May 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 12 May 2021 — USE AMENDMENT FILED
- 22 May 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 May 2021 — TEAS STATEMENT OF USE RECEIVED
- 13 Apr 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT